Midea Group Acquired Controlling Stake in Esaote
The medical imaging specialist will join Midea's Healthcare Division to accelerate global growth.
Updated on Oct. 9, 2026 in Healthcare
Live Poll
Do you believe the acquisition of local medical companies by global tech firms benefits healthcare innovation?
Midea Group has completed the acquisition of a controlling stake in Italian imaging firm Esaote S.p.A. The company will operate as an independent entity within Midea's Healthcare Division to integrate specialized technology portfolios.
Why it matters
The deal aims to boost international competitiveness by combining Midea's vast technology ecosystem with Esaote's specialized ultrasound and MRI systems. Midea plans to scale this footprint through increased investments in R&D and manufacturing operations.
Esaote generated EUR 267 million in 2025 revenue, supported by a 12% R&D investment rate, while its parent Midea Group reported USD 64.3 billion in annual global revenue. The transaction integrates 1,160 employees into Midea's Healthcare Division.
The players
Midea Group
A global technology conglomerate based in Shunde, China, with extensive manufacturing capabilities and a 2026 Fortune Global 500 ranking of 231.
Esaote S.p.A.
An Italian healthcare company specializing in ultrasound and MRI diagnostic systems, employing 1,160 people with a strong international presence.
Franco Fontana
The CEO of Esaote who continues to lead the organization following its integration into the Midea Healthcare Division.
The details
Midea aims to drive growth by applying its manufacturing scale to Esaote's existing product lines. Esaote will maintain its headquarters in Genoa, Italy, and continue operating its R&D and manufacturing facilities in Italy and the Netherlands. CEO Franco Fontana will remain at the helm, ensuring continuity as the company transitions to a subsidiary model within the broader Midea framework.
Timeline
Midea Group was founded in 1968.
Esaote and Midea generated their annual revenue figures in 2025.
Midea completed the acquisition of Esaote on October 9, 2026.
Market Landscape
This acquisition follows a wider trend of industrial conglomerates seeking to diversify into specialized healthcare segments to bolster global competitiveness. It marks a significant expansion for Midea's Healthcare Division, which currently seeks to challenge established medical imaging incumbents.
Operators in the medical imaging space should watch how Midea's capital injection affects Esaote's product pricing and R&D output in the coming quarters. Monitor whether this integration leads to more aggressive pricing or faster feature innovation cycles for MRI and ultrasound hardware.
The takeaway
Large-scale acquisitions by global conglomerates often trigger shifts in pricing and R&D support for legacy customers. Healthcare operators should audit their current equipment lifecycles and evaluate if new ownership changes the support or upgrade roadmap for their existing diagnostic hardware.
Further reading
For more on industry consolidation trends, visit the Healthcare section.
Live Poll
Do you believe the acquisition of local medical companies by global tech firms benefits healthcare innovation?
